Piroxicam and Cholecystitis chronic - a phase IV clinical study of FDA data

Summary:

Cholecystitis chronic is reported as a side effect among people who take Piroxicam (piroxicam), especially for people who are male, 20-29 old, also take Lasix, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Cholecystitis chronic when taking Piroxicam. It is created by eHealthMe based on reports of 8,414 people who have side effects when taking Piroxicam from the FDA, and is updated regularly.

What is Piroxicam?

Piroxicam has active ingredients of piroxicam. It is often used in arthritis. eHealthMe is studying from 8,582 Piroxicam users. Check the latest studies of Piroxicam.

What is Cholecystitis chronic?

Cholecystitis chronic (long lasting infection of gallbladder) is found to be associated with 871 drugs and 926 conditions by eHealthMe. Check the latest studies of Cholecystitis chronic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

8,414 people reported to have side effects when taking Piroxicam.
Among them, 19 people (0.23%) have Cholecystitis chronic.

Could Piroxicam cause Cholecystitis chronic?

Among these 19 people:

What is the gender of people who have Cholecystitis chronic when taking Piroxicam? *

female: 50 %
male: 50 %

What is the age of people who have Cholecystitis chronic when taking Piroxicam? *

What are other drugs people take besides Piroxicam? *

What are other side effects people have besides Cholecystitis chronic? *

Drowsiness: 11 people, 57.89%
Hearing Loss: 10 people, 52.63%
Dyspnea Exertional: 10 people, 52.63%
Middle Insomnia (difficulty returning to sleep after awakening either in the middle of the night): 10 people, 52.63%
Metabolic Syndrome (a combination of the medical disorders that, when occurring together, increase the risk of developing cardiovascular disease): 10 people, 52.63%
Memory Loss: 10 people, 52.63%
Left Ventricular Dysfunction: 10 people, 52.63%
Joint Pain: 10 people, 52.63%
Itching: 10 people, 52.63%
Insomnia (sleeplessness): 10 people, 52.63%

What are the existing conditions these people have? *

High Blood Pressure: 10 people, 52.63%
Cardiac Failure: 10 people, 52.63%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 10 people, 52.63%
Myocarditis (inflammation of heart muscle myocardium): 9 people, 47.37%
Congestive Cardiomyopathy (weakening of heart muscle): 9 people, 47.37%
Local Anaesthesia: 8 people, 42.11%
Anaesthesia: 8 people, 42.11%
Birth Control: 6 people, 31.58%
Premenstrual Syndrome: 1 person, 5.26%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Piroxicam and have Cholecystitis chronic?

- Check whether Cholecystitis chronic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Piroxicam:

Piroxicam (8,582 reports)

Browse all side effects of Piroxicam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cholecystitis chronic:

Cholecystitis chronic (871 drugs)

Browse all the conditions that are associated with Cholecystitis chronic:

Cholecystitis chronic (926 conditions)

Related publications that referenced our studies

Kola E, Bakalli I, Celaj E, Lluka R, Heta S, Sallabanda S, "Stomach perforation from piroxicam poisoning", Paediatrics Today, 2012 Jun .
Kola E, Bakalli I, Celaj E, Lluka R, Heta S, Sallabanda S, "Stomach perforation from piroxicam poisoning", Paediatrics Today, 2012 Jun .

How the study uses the data?

The study uses data from the FDA. It is based on piroxicam (the active ingredients of Piroxicam) and Piroxicam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.